BioNexus Gene Lab Corp (BGLC)
0.604
-0.01
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
0.6041
0.00 (0.00%)
After-Hours: 07:44
BioNexus Gene Lab Total Assets (Quarterly): 11.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.40M |
| September 30, 2023 | 11.47M |
| June 30, 2023 | 7.899M |
| March 31, 2023 | 8.187M |
| December 31, 2022 | 8.740M |
| September 30, 2022 | 7.798M |
| June 30, 2022 | 8.369M |
| March 31, 2022 | 9.175M |
| December 31, 2021 | 9.574M |
| Date | Value |
|---|---|
| September 30, 2021 | 9.765M |
| June 30, 2021 | 9.448M |
| March 31, 2021 | 9.898M |
| December 31, 2020 | 10.12M |
| September 30, 2020 | 1.013M |
| June 30, 2020 | 1.060M |
| March 31, 2020 | 1.127M |
| December 31, 2019 | 1.231M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.013M
Minimum
Sep 2020
11.47M
Maximum
Sep 2023
7.427M
Average
8.740M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Balchem Corp | 1.597B |
| Friedman Industries Inc | 228.96M |
| Solitario Resources Corp | 26.76M |
| Golden Minerals Co | 14.91M |
| Paramount Gold Nevada Corp | 61.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.742M |
| Shareholders Equity (Quarterly) | 9.658M |
| Current Ratio | 4.934 |